Second Sight Medical Products and Nano Precision Medical Announce Merger Agreement to Create Leading Therapeutic Implant Company

Second Sight Medical Products and Nano Precision Medical Announce Merger Agreement to Create Leading Therapeutic Implant Company


Publication/Creation Date
February 7 2022
Creators/Contributors
Nano Precision Medical Inc. (creator)
Adam Mendelsohn (contributor)
Second Sight (contributor)
Gregg Williams (contributor)
AstraZeneca (contributor)
Media Type
Press Release
Persuasive Intent
Advertisement
Discursive Type
Inventions
Description
"LOS ANGELES and EMERYVILLE, CA, Feb. 7, 2022 - Second Sight Medical Products, Inc. (NASDAQ: EYES) (the “Company” or “Second Sight”) and Nano Precision Medical, Inc. (“NPM”), today announced that they have entered into a definitive agreement under which privately held NPM will merge with a wholly owned subsidiary of Second Sight in an all-stock transaction. NPM will be the surviving company and owned by Second Sight. The resulting company will focus on development of innovative drug and device medical implants that treat chronic diseases with high unmet medical need."
HCI Platform
Implantables
Relation to Body
In
Related Body Part
Brain, Eye
Augments
Seeing, Treating

Date archived
March 1 2022
Last edited
May 23 2022
How to cite this entry
Nano Precision Medical Inc.. (February 7 2022). "Second Sight Medical Products and Nano Precision Medical Announce Merger Agreement to Create Leading Therapeutic Implant Company". Fabric of Digital Life. https://fabricofdigitallife.com/Detail/objects/5679